Allianz Asset Management’s Northwest Biotherapeutics, Inc. NWBOW Stock Holding History

Allianz Asset Management’s Portfolio NWBOW Stock Details NWBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-81,620	Closed	-$501K	–	2536
2015 Q2	$501K	Sell	81,620 -81,620	-50%	-$403K	﹤0.01%	2140
2015 Q1	$734K	Hold	163,240	–	–	﹤0.01%	1877
2014 Q4	$432K	Buy	163,240 +81,620	+100%	+$234K	﹤0.01%	2042
2014 Q3	$245K	Hold	81,620	–	–	﹤0.01%	2109
2014 Q2	$310K	Sell	81,620 -8,430	-9%	-$33.4K	﹤0.01%	1703
2014 Q1	$437K	Hold	90,050	–	–	﹤0.01%	1606
2013 Q4	$249K	Hold	90,050	–	–	﹤0.01%	1677
2013 Q3	$180K	Hold	90,050	–	–	﹤0.01%	1682
2013 Q2	$135K	Buy	+90,050	New	+$181K	﹤0.01%	1663

Other funds holding NWBOW

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Allianz Asset Management's NWBOW Position: Q3 2015 in Review

Allianz Asset Management sold out of Northwest Biotherapeutics, Inc. (NWBOW) in Q3 2015, closing a stake of 81,620 shares — an estimated $501K sold.

Allianz Asset Management first reported a position in NWBOW in Q2 2013 and held it in 9 quarters. The position peaked at $734K in Q1 2015. 1 fund tracked by Wall St. Rank holds NWBOW as of Q3 2015.

Allianz Asset Management reported no remaining Northwest Biotherapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Allianz Asset Management sold 81,620 Northwest Biotherapeutics, Inc. shares in Q3 2015, an estimated $501K.
Allianz Asset Management first reported a position in Northwest Biotherapeutics, Inc. in Q2 2013 and held it in 9 quarters.
Allianz Asset Management's Northwest Biotherapeutics, Inc. position peaked at $734K in Q1 2015.
1 fund tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. as of Q3 2015.

Based on Allianz Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.